It was a pleasure to meet Suzanne Wait, Secretariat from All.Can International, at the ECCO 2019 European Cancer Summit in Brussels to discuss the All.Can initiative on inefficiency of cancer care.
1. In what way is the cancer care worldwide inefficient? Does this inefficiency harm current treatment effectiveness and outcomes? (0:08)
2. The ‘All.Can’ international initiative has been established to improve efficiency in cancer care by focusing on what matters to patients. Is attempting to address the care of all cancer types an overly ambitious goal? (1:11)
3. Can you outline the objectives of ‘All.Can’ and explain how the data will be collected? (1:50)
4. What is the duration of the ‘All.Can’ initiative and how many patients and stakeholders will be involved? (3:26)
5. When available, how will the findings of ‘All.Can’ be used; will they influence government policies and improve the care delivered to patients? (4:57)
Suzanne Wait has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Mark Lawler, European Cancer Summit 2022: The ECO-ASCO Special Network
The impact of the Russian invasion on Ukraine and how this has impacted clinical trials and cancer care in Europe. The Special Network on the Impact of the War in Ukraine on Cancer was established by ECO Board and ASCO soon after the war started, and now has representatives of over 300 organisations. In this […]
Mark Lawler, European Cancer Summit, 2022: What is the European Cancer Pulse?
Professor Mark Lawler (Queen’s University Belfast) summarizes the European Cancer Pulse, an exciting new tool that brings together data from 34 European countries and helps determine cancer care disparities on cancer burden, research spending, prevention efforts, early detection, diagnosis and treatment access, survivorship, impact of social determinants and much more. For more information, click here. […]
Mark Lawler, European Cancer Summit 2022: The European Groundshot
The European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission is a unique imitative launched this year aims to identify the challenges in cancer care in Europe. The COVID-19 pandemic has had a significant impact on cancer diagnosis and halted many ongoing clinical trials. In this video, Professor Mark Lawler (Queen’s University Belfast) describes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!